nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00452	0.0917	CbGpPWpGaD
Irbesartan—EDNRA—Endothelin Pathways—CALCA—Paget's disease of bone	0.00378	0.0767	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—Paget's disease of bone	0.00242	0.0491	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—SQSTM1—Paget's disease of bone	0.00223	0.0452	CbGpPWpGaD
Irbesartan—Dysgeusia—Alendronate—Paget's disease of bone	0.00221	0.00233	CcSEcCtD
Irbesartan—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00219	0.00231	CcSEcCtD
Irbesartan—Muscle spasms—Alendronate—Paget's disease of bone	0.00217	0.00228	CcSEcCtD
Irbesartan—Renal failure—Pamidronate—Paget's disease of bone	0.00217	0.00228	CcSEcCtD
Irbesartan—Infection—Etidronic acid—Paget's disease of bone	0.00215	0.00226	CcSEcCtD
Irbesartan—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00214	0.00225	CcSEcCtD
Irbesartan—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00214	0.00225	CcSEcCtD
Irbesartan—Neutropenia—Zoledronate—Paget's disease of bone	0.00211	0.00222	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.0021	0.00221	CcSEcCtD
Irbesartan—Ill-defined disorder—Alendronate—Paget's disease of bone	0.0021	0.0022	CcSEcCtD
Irbesartan—Anaemia—Alendronate—Paget's disease of bone	0.00209	0.0022	CcSEcCtD
Irbesartan—Rhinitis—Risedronate—Paget's disease of bone	0.00209	0.0022	CcSEcCtD
Irbesartan—Pharyngitis—Risedronate—Paget's disease of bone	0.00207	0.00217	CcSEcCtD
Irbesartan—Angioedema—Alendronate—Paget's disease of bone	0.00206	0.00217	CcSEcCtD
Irbesartan—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00206	0.00216	CcSEcCtD
Irbesartan—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00206	0.00216	CcSEcCtD
Irbesartan—Weight increased—Zoledronate—Paget's disease of bone	0.00206	0.00216	CcSEcCtD
Irbesartan—Oedema peripheral—Risedronate—Paget's disease of bone	0.00205	0.00216	CcSEcCtD
Irbesartan—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00205	0.00215	CcSEcCtD
Irbesartan—Urethral disorder—Risedronate—Paget's disease of bone	0.00204	0.00215	CcSEcCtD
Irbesartan—Malaise—Alendronate—Paget's disease of bone	0.00204	0.00214	CcSEcCtD
Irbesartan—Vertigo—Alendronate—Paget's disease of bone	0.00203	0.00213	CcSEcCtD
Irbesartan—Rhinitis—Pamidronate—Paget's disease of bone	0.00198	0.00209	CcSEcCtD
Irbesartan—Renal failure—Zoledronate—Paget's disease of bone	0.00198	0.00208	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00197	0.00207	CcSEcCtD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00197	0.0399	CbGpPWpGaD
Irbesartan—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00196	0.00206	CcSEcCtD
Irbesartan—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00196	0.00206	CcSEcCtD
Irbesartan—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00195	0.00206	CcSEcCtD
Irbesartan—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00195	0.00205	CcSEcCtD
Irbesartan—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00194	0.00204	CcSEcCtD
Irbesartan—Tinnitus—Risedronate—Paget's disease of bone	0.00194	0.00204	CcSEcCtD
Irbesartan—Urethral disorder—Pamidronate—Paget's disease of bone	0.00194	0.00204	CcSEcCtD
Irbesartan—Cardiac disorder—Risedronate—Paget's disease of bone	0.00193	0.00203	CcSEcCtD
Irbesartan—Myalgia—Alendronate—Paget's disease of bone	0.00192	0.00202	CcSEcCtD
Irbesartan—Chest pain—Alendronate—Paget's disease of bone	0.00192	0.00202	CcSEcCtD
Irbesartan—Dyspepsia—Etidronic acid—Paget's disease of bone	0.0019	0.002	CcSEcCtD
Irbesartan—Discomfort—Alendronate—Paget's disease of bone	0.0019	0.002	CcSEcCtD
Irbesartan—Angiopathy—Risedronate—Paget's disease of bone	0.00189	0.00199	CcSEcCtD
Irbesartan—Immune system disorder—Risedronate—Paget's disease of bone	0.00188	0.00198	CcSEcCtD
Irbesartan—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00188	0.00198	CcSEcCtD
Irbesartan—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00188	0.00197	CcSEcCtD
Irbesartan—Arrhythmia—Risedronate—Paget's disease of bone	0.00186	0.00196	CcSEcCtD
Irbesartan—JUN—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00185	0.0376	CbGpPWpGaD
Irbesartan—Constipation—Etidronic acid—Paget's disease of bone	0.00185	0.00195	CcSEcCtD
Irbesartan—Bradycardia—Zoledronate—Paget's disease of bone	0.00184	0.00194	CcSEcCtD
Irbesartan—Flushing—Pamidronate—Paget's disease of bone	0.00184	0.00193	CcSEcCtD
Irbesartan—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00184	0.00193	CcSEcCtD
Irbesartan—Infection—Alendronate—Paget's disease of bone	0.00183	0.00193	CcSEcCtD
Irbesartan—Malnutrition—Risedronate—Paget's disease of bone	0.00181	0.00191	CcSEcCtD
Irbesartan—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.0018	0.00189	CcSEcCtD
Irbesartan—Angiopathy—Pamidronate—Paget's disease of bone	0.0018	0.00189	CcSEcCtD
Irbesartan—JUN—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00179	0.0363	CbGpPWpGaD
Irbesartan—Immune system disorder—Pamidronate—Paget's disease of bone	0.00179	0.00188	CcSEcCtD
Irbesartan—Flatulence—Risedronate—Paget's disease of bone	0.00179	0.00188	CcSEcCtD
Irbesartan—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00179	0.00188	CcSEcCtD
Irbesartan—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00178	0.00188	CcSEcCtD
Irbesartan—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00178	0.00188	CcSEcCtD
Irbesartan—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00178	0.00187	CcSEcCtD
Irbesartan—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00178	0.00187	CcSEcCtD
Irbesartan—Chills—Pamidronate—Paget's disease of bone	0.00178	0.00187	CcSEcCtD
Irbesartan—Urethral disorder—Zoledronate—Paget's disease of bone	0.00177	0.00186	CcSEcCtD
Irbesartan—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00177	0.00186	CcSEcCtD
Irbesartan—Muscle spasms—Risedronate—Paget's disease of bone	0.00174	0.00183	CcSEcCtD
Irbesartan—Erythema—Pamidronate—Paget's disease of bone	0.00172	0.00181	CcSEcCtD
Irbesartan—Malnutrition—Pamidronate—Paget's disease of bone	0.00172	0.00181	CcSEcCtD
Irbesartan—Urticaria—Etidronic acid—Paget's disease of bone	0.00172	0.00181	CcSEcCtD
Irbesartan—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00171	0.0018	CcSEcCtD
Irbesartan—Tension—Pamidronate—Paget's disease of bone	0.00169	0.00178	CcSEcCtD
Irbesartan—Dysgeusia—Pamidronate—Paget's disease of bone	0.00169	0.00177	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00168	0.00177	CcSEcCtD
Irbesartan—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00168	0.00176	CcSEcCtD
Irbesartan—Flushing—Zoledronate—Paget's disease of bone	0.00168	0.00176	CcSEcCtD
Irbesartan—Anaemia—Risedronate—Paget's disease of bone	0.00168	0.00176	CcSEcCtD
Irbesartan—Nervousness—Pamidronate—Paget's disease of bone	0.00167	0.00176	CcSEcCtD
Irbesartan—Muscle spasms—Pamidronate—Paget's disease of bone	0.00166	0.00174	CcSEcCtD
Irbesartan—Angioedema—Risedronate—Paget's disease of bone	0.00166	0.00174	CcSEcCtD
Irbesartan—JUN—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00165	0.0334	CbGpPWpGaD
Irbesartan—Angiopathy—Zoledronate—Paget's disease of bone	0.00164	0.00173	CcSEcCtD
Irbesartan—Immune system disorder—Zoledronate—Paget's disease of bone	0.00163	0.00172	CcSEcCtD
Irbesartan—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00163	0.00171	CcSEcCtD
Irbesartan—Vertigo—Risedronate—Paget's disease of bone	0.00163	0.00171	CcSEcCtD
Irbesartan—Syncope—Risedronate—Paget's disease of bone	0.00163	0.00171	CcSEcCtD
Irbesartan—Dyspepsia—Alendronate—Paget's disease of bone	0.00162	0.00171	CcSEcCtD
Irbesartan—Chills—Zoledronate—Paget's disease of bone	0.00162	0.00171	CcSEcCtD
Irbesartan—Arrhythmia—Zoledronate—Paget's disease of bone	0.00162	0.0017	CcSEcCtD
Irbesartan—JUN—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.0016	0.0325	CbGpPWpGaD
Irbesartan—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.0016	0.00168	CcSEcCtD
Irbesartan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00159	0.00168	CcSEcCtD
Irbesartan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00159	0.00168	CcSEcCtD
Irbesartan—Anaemia—Pamidronate—Paget's disease of bone	0.00159	0.00168	CcSEcCtD
Irbesartan—Agitation—Pamidronate—Paget's disease of bone	0.00158	0.00167	CcSEcCtD
Irbesartan—Cough—Risedronate—Paget's disease of bone	0.00158	0.00166	CcSEcCtD
Irbesartan—Constipation—Alendronate—Paget's disease of bone	0.00158	0.00166	CcSEcCtD
Irbesartan—Pain—Alendronate—Paget's disease of bone	0.00158	0.00166	CcSEcCtD
Irbesartan—Angioedema—Pamidronate—Paget's disease of bone	0.00157	0.00166	CcSEcCtD
Irbesartan—Malnutrition—Zoledronate—Paget's disease of bone	0.00157	0.00166	CcSEcCtD
Irbesartan—Erythema—Zoledronate—Paget's disease of bone	0.00157	0.00166	CcSEcCtD
Irbesartan—Hypertension—Risedronate—Paget's disease of bone	0.00156	0.00165	CcSEcCtD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.00156	0.0316	CbGpPWpGaD
Irbesartan—Malaise—Pamidronate—Paget's disease of bone	0.00155	0.00163	CcSEcCtD
Irbesartan—Syncope—Pamidronate—Paget's disease of bone	0.00155	0.00163	CcSEcCtD
Irbesartan—Arthralgia—Risedronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Myalgia—Risedronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Chest pain—Risedronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Leukopenia—Pamidronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Dysgeusia—Zoledronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Anxiety—Risedronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00153	0.00161	CcSEcCtD
Irbesartan—Pruritus—Etidronic acid—Paget's disease of bone	0.00153	0.00161	CcSEcCtD
Irbesartan—JUN—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.00152	0.0309	CbGpPWpGaD
Irbesartan—Feeling abnormal—Alendronate—Paget's disease of bone	0.00152	0.0016	CcSEcCtD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00152	0.0308	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00152	0.0308	CbGpPWpGaD
Irbesartan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00151	0.00159	CcSEcCtD
Irbesartan—Muscle spasms—Zoledronate—Paget's disease of bone	0.00151	0.00159	CcSEcCtD
Irbesartan—Dry mouth—Risedronate—Paget's disease of bone	0.00151	0.00159	CcSEcCtD
Irbesartan—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00151	0.00159	CcSEcCtD
Irbesartan—Cough—Pamidronate—Paget's disease of bone	0.0015	0.00158	CcSEcCtD
Irbesartan—Hypertension—Pamidronate—Paget's disease of bone	0.00149	0.00156	CcSEcCtD
Irbesartan—Vision blurred—Zoledronate—Paget's disease of bone	0.00148	0.00156	CcSEcCtD
Irbesartan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00148	0.00156	CcSEcCtD
Irbesartan—Tremor—Zoledronate—Paget's disease of bone	0.00147	0.00155	CcSEcCtD
Irbesartan—Infection—Risedronate—Paget's disease of bone	0.00147	0.00155	CcSEcCtD
Irbesartan—Arthralgia—Pamidronate—Paget's disease of bone	0.00147	0.00154	CcSEcCtD
Irbesartan—Myalgia—Pamidronate—Paget's disease of bone	0.00147	0.00154	CcSEcCtD
Irbesartan—Urticaria—Alendronate—Paget's disease of bone	0.00146	0.00154	CcSEcCtD
Irbesartan—Anxiety—Pamidronate—Paget's disease of bone	0.00146	0.00154	CcSEcCtD
Irbesartan—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00146	0.00154	CcSEcCtD
Irbesartan—Abdominal pain—Alendronate—Paget's disease of bone	0.00146	0.00153	CcSEcCtD
Irbesartan—Body temperature increased—Alendronate—Paget's disease of bone	0.00146	0.00153	CcSEcCtD
Irbesartan—Shock—Risedronate—Paget's disease of bone	0.00146	0.00153	CcSEcCtD
Irbesartan—Anaemia—Zoledronate—Paget's disease of bone	0.00145	0.00153	CcSEcCtD
Irbesartan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00145	0.00153	CcSEcCtD
Irbesartan—Discomfort—Pamidronate—Paget's disease of bone	0.00145	0.00152	CcSEcCtD
Irbesartan—Agitation—Zoledronate—Paget's disease of bone	0.00145	0.00152	CcSEcCtD
Irbesartan—JUN—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00144	0.0293	CbGpPWpGaD
Irbesartan—Angioedema—Zoledronate—Paget's disease of bone	0.00144	0.00151	CcSEcCtD
Irbesartan—Skin disorder—Risedronate—Paget's disease of bone	0.00144	0.00151	CcSEcCtD
Irbesartan—Malaise—Zoledronate—Paget's disease of bone	0.00142	0.00149	CcSEcCtD
Irbesartan—Vertigo—Zoledronate—Paget's disease of bone	0.00141	0.00149	CcSEcCtD
Irbesartan—Syncope—Zoledronate—Paget's disease of bone	0.00141	0.00148	CcSEcCtD
Irbesartan—Leukopenia—Zoledronate—Paget's disease of bone	0.00141	0.00148	CcSEcCtD
Irbesartan—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00141	0.00148	CcSEcCtD
Irbesartan—Oedema—Pamidronate—Paget's disease of bone	0.00141	0.00148	CcSEcCtD
Irbesartan—Infection—Pamidronate—Paget's disease of bone	0.0014	0.00147	CcSEcCtD
Irbesartan—Shock—Pamidronate—Paget's disease of bone	0.00138	0.00146	CcSEcCtD
Irbesartan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00138	0.00145	CcSEcCtD
Irbesartan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00138	0.00145	CcSEcCtD
Irbesartan—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00138	0.00145	CcSEcCtD
Irbesartan—Vomiting—Etidronic acid—Paget's disease of bone	0.00138	0.00145	CcSEcCtD
Irbesartan—Cough—Zoledronate—Paget's disease of bone	0.00137	0.00144	CcSEcCtD
Irbesartan—Tachycardia—Pamidronate—Paget's disease of bone	0.00137	0.00144	CcSEcCtD
Irbesartan—Rash—Etidronic acid—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Dermatitis—Etidronic acid—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Hypertension—Zoledronate—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Headache—Etidronic acid—Paget's disease of bone	0.00136	0.00143	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00135	0.00142	CcSEcCtD
Irbesartan—Anorexia—Pamidronate—Paget's disease of bone	0.00134	0.00141	CcSEcCtD
Irbesartan—Myalgia—Zoledronate—Paget's disease of bone	0.00134	0.00141	CcSEcCtD
Irbesartan—Chest pain—Zoledronate—Paget's disease of bone	0.00134	0.00141	CcSEcCtD
Irbesartan—Arthralgia—Zoledronate—Paget's disease of bone	0.00134	0.00141	CcSEcCtD
Irbesartan—Anxiety—Zoledronate—Paget's disease of bone	0.00134	0.0014	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00133	0.0014	CcSEcCtD
Irbesartan—Paraesthesia—Risedronate—Paget's disease of bone	0.00133	0.0014	CcSEcCtD
Irbesartan—Discomfort—Zoledronate—Paget's disease of bone	0.00132	0.00139	CcSEcCtD
Irbesartan—Asthenia—Alendronate—Paget's disease of bone	0.00132	0.00139	CcSEcCtD
Irbesartan—Dyspnoea—Risedronate—Paget's disease of bone	0.00132	0.00139	CcSEcCtD
Irbesartan—Hypotension—Pamidronate—Paget's disease of bone	0.00131	0.00138	CcSEcCtD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TNFRSF11B—Paget's disease of bone	0.00131	0.0267	CbGpPWpGaD
Irbesartan—Dry mouth—Zoledronate—Paget's disease of bone	0.00131	0.00138	CcSEcCtD
Irbesartan—Pruritus—Alendronate—Paget's disease of bone	0.0013	0.00137	CcSEcCtD
Irbesartan—Dyspepsia—Risedronate—Paget's disease of bone	0.0013	0.00137	CcSEcCtD
Irbesartan—Nausea—Etidronic acid—Paget's disease of bone	0.00129	0.00135	CcSEcCtD
Irbesartan—Oedema—Zoledronate—Paget's disease of bone	0.00128	0.00135	CcSEcCtD
Irbesartan—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00128	0.00135	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00128	0.00135	CcSEcCtD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.00128	0.026	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00128	0.00134	CcSEcCtD
Irbesartan—Infection—Zoledronate—Paget's disease of bone	0.00128	0.00134	CcSEcCtD
Irbesartan—Fatigue—Risedronate—Paget's disease of bone	0.00128	0.00134	CcSEcCtD
Irbesartan—Pain—Risedronate—Paget's disease of bone	0.00127	0.00133	CcSEcCtD
Irbesartan—Constipation—Risedronate—Paget's disease of bone	0.00127	0.00133	CcSEcCtD
Irbesartan—Shock—Zoledronate—Paget's disease of bone	0.00126	0.00133	CcSEcCtD
Irbesartan—Paraesthesia—Pamidronate—Paget's disease of bone	0.00126	0.00133	CcSEcCtD
Irbesartan—Diarrhoea—Alendronate—Paget's disease of bone	0.00126	0.00133	CcSEcCtD
Irbesartan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00126	0.00132	CcSEcCtD
Irbesartan—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00126	0.00132	CcSEcCtD
Irbesartan—Dyspnoea—Pamidronate—Paget's disease of bone	0.00125	0.00132	CcSEcCtD
Irbesartan—Tachycardia—Zoledronate—Paget's disease of bone	0.00125	0.00132	CcSEcCtD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.00125	0.0254	CbGpPWpGaD
Irbesartan—Somnolence—Pamidronate—Paget's disease of bone	0.00125	0.00131	CcSEcCtD
Irbesartan—Skin disorder—Zoledronate—Paget's disease of bone	0.00125	0.00131	CcSEcCtD
Irbesartan—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00124	0.00131	CcSEcCtD
Irbesartan—Dyspepsia—Pamidronate—Paget's disease of bone	0.00124	0.0013	CcSEcCtD
Irbesartan—Anorexia—Zoledronate—Paget's disease of bone	0.00122	0.00129	CcSEcCtD
Irbesartan—Decreased appetite—Pamidronate—Paget's disease of bone	0.00122	0.00129	CcSEcCtD
Irbesartan—Dizziness—Alendronate—Paget's disease of bone	0.00122	0.00128	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00121	0.00128	CcSEcCtD
Irbesartan—Fatigue—Pamidronate—Paget's disease of bone	0.00121	0.00128	CcSEcCtD
Irbesartan—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00121	0.00127	CcSEcCtD
Irbesartan—Pain—Pamidronate—Paget's disease of bone	0.0012	0.00126	CcSEcCtD
Irbesartan—Constipation—Pamidronate—Paget's disease of bone	0.0012	0.00126	CcSEcCtD
Irbesartan—Hypotension—Zoledronate—Paget's disease of bone	0.0012	0.00126	CcSEcCtD
Irbesartan—Urticaria—Risedronate—Paget's disease of bone	0.00118	0.00124	CcSEcCtD
Irbesartan—Vomiting—Alendronate—Paget's disease of bone	0.00117	0.00123	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00117	0.00123	CcSEcCtD
Irbesartan—Abdominal pain—Risedronate—Paget's disease of bone	0.00117	0.00123	CcSEcCtD
Irbesartan—Body temperature increased—Risedronate—Paget's disease of bone	0.00117	0.00123	CcSEcCtD
Irbesartan—Rash—Alendronate—Paget's disease of bone	0.00116	0.00122	CcSEcCtD
Irbesartan—Dermatitis—Alendronate—Paget's disease of bone	0.00116	0.00122	CcSEcCtD
Irbesartan—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00116	0.00122	CcSEcCtD
Irbesartan—Headache—Alendronate—Paget's disease of bone	0.00115	0.00121	CcSEcCtD
Irbesartan—Paraesthesia—Zoledronate—Paget's disease of bone	0.00115	0.00121	CcSEcCtD
Irbesartan—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00115	0.00121	CcSEcCtD
Irbesartan—Dyspnoea—Zoledronate—Paget's disease of bone	0.00115	0.0012	CcSEcCtD
Irbesartan—Somnolence—Zoledronate—Paget's disease of bone	0.00114	0.0012	CcSEcCtD
Irbesartan—Dyspepsia—Zoledronate—Paget's disease of bone	0.00113	0.00119	CcSEcCtD
Irbesartan—Decreased appetite—Zoledronate—Paget's disease of bone	0.00112	0.00117	CcSEcCtD
Irbesartan—Abdominal pain—Pamidronate—Paget's disease of bone	0.00111	0.00117	CcSEcCtD
Irbesartan—Body temperature increased—Pamidronate—Paget's disease of bone	0.00111	0.00117	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00111	0.00117	CcSEcCtD
Irbesartan—Fatigue—Zoledronate—Paget's disease of bone	0.00111	0.00116	CcSEcCtD
Irbesartan—Constipation—Zoledronate—Paget's disease of bone	0.0011	0.00116	CcSEcCtD
Irbesartan—Pain—Zoledronate—Paget's disease of bone	0.0011	0.00116	CcSEcCtD
Irbesartan—Nausea—Alendronate—Paget's disease of bone	0.0011	0.00115	CcSEcCtD
Irbesartan—Hypersensitivity—Risedronate—Paget's disease of bone	0.00109	0.00115	CcSEcCtD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00107	0.0218	CbGpPWpGaD
Irbesartan—Asthenia—Risedronate—Paget's disease of bone	0.00106	0.00112	CcSEcCtD
Irbesartan—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00106	0.00111	CcSEcCtD
Irbesartan—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00105	0.0011	CcSEcCtD
Irbesartan—Pruritus—Risedronate—Paget's disease of bone	0.00105	0.0011	CcSEcCtD
Irbesartan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00104	0.00109	CcSEcCtD
Irbesartan—Urticaria—Zoledronate—Paget's disease of bone	0.00102	0.00107	CcSEcCtD
Irbesartan—Abdominal pain—Zoledronate—Paget's disease of bone	0.00102	0.00107	CcSEcCtD
Irbesartan—Body temperature increased—Zoledronate—Paget's disease of bone	0.00102	0.00107	CcSEcCtD
Irbesartan—Diarrhoea—Risedronate—Paget's disease of bone	0.00101	0.00106	CcSEcCtD
Irbesartan—Asthenia—Pamidronate—Paget's disease of bone	0.00101	0.00106	CcSEcCtD
Irbesartan—Pruritus—Pamidronate—Paget's disease of bone	0.000995	0.00105	CcSEcCtD
Irbesartan—Dizziness—Risedronate—Paget's disease of bone	0.000978	0.00103	CcSEcCtD
Irbesartan—Diarrhoea—Pamidronate—Paget's disease of bone	0.000962	0.00101	CcSEcCtD
Irbesartan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000946	0.000995	CcSEcCtD
Irbesartan—Vomiting—Risedronate—Paget's disease of bone	0.000941	0.000989	CcSEcCtD
Irbesartan—Rash—Risedronate—Paget's disease of bone	0.000933	0.000981	CcSEcCtD
Irbesartan—Dermatitis—Risedronate—Paget's disease of bone	0.000932	0.00098	CcSEcCtD
Irbesartan—Dizziness—Pamidronate—Paget's disease of bone	0.00093	0.000978	CcSEcCtD
Irbesartan—Headache—Risedronate—Paget's disease of bone	0.000927	0.000975	CcSEcCtD
Irbesartan—Asthenia—Zoledronate—Paget's disease of bone	0.000922	0.000969	CcSEcCtD
Irbesartan—Pruritus—Zoledronate—Paget's disease of bone	0.000909	0.000956	CcSEcCtD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000903	0.0183	CbGpPWpGaD
Irbesartan—Vomiting—Pamidronate—Paget's disease of bone	0.000894	0.00094	CcSEcCtD
Irbesartan—Rash—Pamidronate—Paget's disease of bone	0.000887	0.000933	CcSEcCtD
Irbesartan—Dermatitis—Pamidronate—Paget's disease of bone	0.000886	0.000932	CcSEcCtD
Irbesartan—JUN—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000881	0.0179	CbGpPWpGaD
Irbesartan—Headache—Pamidronate—Paget's disease of bone	0.000881	0.000927	CcSEcCtD
Irbesartan—Diarrhoea—Zoledronate—Paget's disease of bone	0.000879	0.000924	CcSEcCtD
Irbesartan—Nausea—Risedronate—Paget's disease of bone	0.000879	0.000924	CcSEcCtD
Irbesartan—JUN—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.00087	0.0177	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00086	0.0175	CbGpPWpGaD
Irbesartan—Dizziness—Zoledronate—Paget's disease of bone	0.000849	0.000893	CcSEcCtD
Irbesartan—Nausea—Pamidronate—Paget's disease of bone	0.000835	0.000879	CcSEcCtD
Irbesartan—JUN—Direct p53 effectors—PML—Paget's disease of bone	0.00083	0.0168	CbGpPWpGaD
Irbesartan—Vomiting—Zoledronate—Paget's disease of bone	0.000817	0.000859	CcSEcCtD
Irbesartan—Rash—Zoledronate—Paget's disease of bone	0.00081	0.000852	CcSEcCtD
Irbesartan—Dermatitis—Zoledronate—Paget's disease of bone	0.000809	0.000851	CcSEcCtD
Irbesartan—Headache—Zoledronate—Paget's disease of bone	0.000805	0.000846	CcSEcCtD
Irbesartan—JUN—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000781	0.0159	CbGpPWpGaD
Irbesartan—Nausea—Zoledronate—Paget's disease of bone	0.000763	0.000803	CcSEcCtD
Irbesartan—JUN—Cellular responses to stress—VCP—Paget's disease of bone	0.000739	0.015	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000722	0.0146	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000712	0.0145	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000702	0.0142	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000647	0.0131	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.000642	0.013	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—PML—Paget's disease of bone	0.000621	0.0126	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CALCA—Paget's disease of bone	0.000475	0.00965	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CALCA—Paget's disease of bone	0.000373	0.00757	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000269	0.00545	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VCP—Paget's disease of bone	0.000254	0.00516	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CALCA—Paget's disease of bone	0.000244	0.00495	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000211	0.00428	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VCP—Paget's disease of bone	0.000199	0.00405	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000191	0.00389	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000182	0.00369	CbGpPWpGaD
Irbesartan—JUN—Immune System—NUP205—Paget's disease of bone	0.000176	0.00357	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NUP205—Paget's disease of bone	0.000169	0.00343	CbGpPWpGaD
Irbesartan—JUN—Immune System—PML—Paget's disease of bone	0.000156	0.00316	CbGpPWpGaD
Irbesartan—JUN—Immune System—INPP5D—Paget's disease of bone	0.00015	0.00305	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VCP—Paget's disease of bone	0.000149	0.00302	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000148	0.00301	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CALCA—Paget's disease of bone	0.000144	0.00293	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—INPP5D—Paget's disease of bone	0.000144	0.00292	CbGpPWpGaD
Irbesartan—JUN—Immune System—SQSTM1—Paget's disease of bone	0.000135	0.00273	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000118	0.00239	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000116	0.00236	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CALCA—Paget's disease of bone	0.000113	0.0023	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	9.57e-05	0.00194	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NUP205—Paget's disease of bone	9.5e-05	0.00193	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SQSTM1—Paget's disease of bone	8.7e-05	0.00177	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CALCA—Paget's disease of bone	8.45e-05	0.00172	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	8.18e-05	0.00166	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—INPP5D—Paget's disease of bone	8.1e-05	0.00165	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NUP205—Paget's disease of bone	6.14e-05	0.00125	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—INPP5D—Paget's disease of bone	5.23e-05	0.00106	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NUP205—Paget's disease of bone	5.04e-05	0.00102	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NUP205—Paget's disease of bone	5e-05	0.00101	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	4.3e-05	0.000872	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NUP205—Paget's disease of bone	4.27e-05	0.000867	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	4.26e-05	0.000865	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	3.64e-05	0.000739	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NUP205—Paget's disease of bone	3.3e-05	0.000669	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	2.81e-05	0.00057	CbGpPWpGaD
